C
Cellabmed
The startup develops cell and antibody therapeutics for cancer treatment, focusing on immune cell therapy that enhances cancer cell recognition and therapeutic efficacy. This approach provides patients with more effective treatment options, improving healthcare outcomes in oncology.
Traction –/10
Seoul, South Korea · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops cell and antibody therapeutics for cancer treatment, focusing on immune cell therapy that enhances cancer cell recognition and therapeutic efficacy. This approach provides patients with more effective treatment options, improving healthcare outcomes in oncology.